Log In
Print this Print this

warfarin (Coumadin)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionSmall molecule compound that inhibits the synthesis of vitamin K-dependent clotting factors
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationVenous thromboembolism (VTE)
Indication DetailsPrevent recurrent venous thromboembolism (VE)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today